1. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu
T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G,
Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa
K, Nakao K. Stomach is a major source of circulating ghrelin,
and feeding state determines plasma ghrelin-like immunoreactivity
levels in humans. J Clin Endocrinol Metab
2001; 86: 4753-4758.
2. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino
MA, Kasuga M, Antagonism of ghrelin receptor reduces
food intake and body weight gain in mice. Gut 2003; 52:
947-952.
3. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni
S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti
M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia
F, Prat M, Muccioli G, Ghigo E, Graziani A. Ghrelin
and des-acyl ghrelin inhibit cell death in cardiomyocytes and
endothelial cells through ERK1/2 and PI 3-kinase/AKT. J
Cell Biol 2002; 159:1029-1037.
4. Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko
M, Jaffe CA. Ghrelin secretion in humans is sexually dimorphic,
suppressed by somatostatin, and not affected by the
ambient growth hormone levels. J Clin Endocrinol Metab
2003; 88: 2180–2184.
5. Bedendi I, Alloatti G, Marcantoni A, Malan D, Catapano F,
Ghe C, Deghenghi R, Ghigo E, Muccioli G. Cardiac effects
of ghrelin and its endogenous derivatives des-octanoyl ghrelin
and des-Gln14-ghrelin. Eur J Pharmacol 2003; 22: 476:
87-95.
6. Bellone S, Rapa A, Vivenza D, Castellino N, Petri A, Bellone
J, Me E, Broglio F, Prodam F, Ghigo E, Bona G. Circulating
ghrelin levels as function of gender, pubertal status and
adiposity in childhood. J Endocrinol Invest 2002; 25: 13-15.
7. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti
M, Lely AJ, Deghenghi R, Ghigo E. Ghrelin, a natural GH
secretagogue produced by the stomach, induces hyperglycemia
and reduces insulin secretion in humans. J Clin Endocrinol
Metab 2001; 86: 5083–5086.
8. Broglio F, Benso A, Gottero C, Prodam F, Gauna C, Filtri L,
Arvat E, van der Lely AJ, Deghenghi R, Ghigo E. Non-acylated
ghrelin does not possess the pituitaric and pancreatic
endocrine activity of acylated ghrelin in humans. J Endocrinol
Invest 2003; 26: 192-196.
09. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti
M, Abribat T, Van Der Lely AJ, Ghigo E. Non-acylated
ghrelin counteracts the metabolic but not the neuroendocrine
response to acylated ghrelin in humans. J Clin Endocrinol
Metab 2004; 89: 3062-3065.
10. Cappiello V, Ronchi C, Morpurgo PS, Epaminonda P, Arosio
M, Beck-Peccoz P, Spada A. Circulating ghrelin levels in
basal conditions and during glucose tolerance test in acromegalic
patients. Eur J Endocrinol 2002; 147: 189–194.
11. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani
A, Deghenghi R, Reissmann T, Ghigo E, Muccioli G.
Identification, characterization, and biological activity of
specific receptors for natural (ghrelin) and synthetic growth
hormone secretagogues and analogs in human breast carcinomas
and cell lines. J Clin Endocrinol Metab 2001;
86:1738-1745.
12. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, Catapano
F, Deghenghi R, Ghigo E, Papotti M, Muccioli G. Expression
of ghrelin and biological activity of specific receptors for
ghrelin and des-acyl ghrelin in human prostate neoplasms
and related cell lines. Eur J Endocrinol 2004; 150:173-184.
13. Chanoine JP, Wong AC. Ghrelin gene expression is markedly
higher in fetal pancreas compared with fetal stomach:
effect of maternal fasting. Endocrinology 2004; 145:3813-
3820.
14. Cheng K, Chan WW, Barreto A Jr, Convey EM, Smith RG.
The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-
NH2 on growth hormone (GH)-releasing factor-stimulated
GH release and intracellular adenosine 3',5'-monophosphate
accumulation in rat primary pituitary cell culture. Endocrinology
1989; 124: 2791–2798,.
15. Cortelazzi D, Cappiello V, Morpurgo PS, Ronzoni S, Nobile
De Santis MS, Cetin I, Beck-Peccoz P, Spada A. Circulating
levels of ghrelin in human fetuses. Eur J Endocrinol 2003;
149:111-116.
16. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse
BE, Weigle DS. A preprandial rise in plasma ghrelin levels
suggests a role in meal initiation in humans. Diabetes 2001;
50: 1714-1719.
Ghrelin and functions
‹stanbul T›p Fakültesi Dergisi Cilt / Volume: 70 • Say› / Number: 3 • Y›l/Year: 2007
- 89 -
17. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK,
Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced
weight loss or gastric bypass surgery. N Engl J Med
2002; 346: 1623–1630.
18. Dall R, Kanaley J, Hansen TK, Moller N, Christiansen JS,
Hosoda H, Kangawa K, Jorgensen JO. Plasma ghrelin levels
during exercise in healthy subjects and in growth hormonedeficient
patients. Eur J Endocrinol 2002; 147: 65-70.
19. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS,
Suganuma T, Matsukura S, Kangawa K, Nakazato M. Ghrelin,
a novel growth hormone-releasing acylated peptide, is
synthesized in a distinct endocrine cell type in the gastrointestinal
tracts of rats and humans. Endocrinology 2000; 141:
4255-4261.
20. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K,
Matsukura S. Ghrelin acts in the central nervous system to
stimulate gastric acid secretion. Biochem Biophys Res Commun
2001; 280: 904-907.
21. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS,
Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada
T. Ghrelin is present in pancreatic alpha-cells of humans
and rats and stimulates insulin secretion. Diabetes 2002;
51:124-129.
22. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK,
Palaniappan R, Lillard JW, Taub DD. Ghrelin inhibits leptinand
activation-induced proinflammatory cytokine expression
by human monocytes and T cells. J Clin Invest 2004; 114:
57-66.
23. Dornonville De La Cour C, Lindstrom E, Norlen P, Hakanson
R. Ghrelin stimulates gastric emptying but is without effect
on acid secretion and gastric endocrine cells. Regul Pept
2004; 120: 23-32.
24. Druce M, Bloom SR. Central regulators of food intake. Curr
Opin Clin Nutr Metab Care 2003; 6: 361-367.
25. Dzaja A, Dalal MA, Himmerich H, Uhr M, Pollmacher T,
Schuld A. Sleep enhances nocturnal plasma ghrelin levels in
healthy subjects. Am J Physiol Endocrinol Metab 2004;
286: 963-967.
26. Eden-Engstrom B, Burman P, Holdstock C, Karlsson FA. Effects
of growth hormone (GH) on ghrelin, leptin, and adiponectin
in GH-deficient patients. J Clin Endocrinol Metab
2003; 88; 5193-5198.
27. Erdmann J, Lippl F, Schusdziarra V. Differential effect of
protein and fat on plasma ghrelin levels in man. Regul Pept
2003; 116: 101-107.
28. Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw
SL. Serum ghrelin levels in acromegaly: effects of surgical
and long-acting octreotide therapy. J Clin Endocrinol Metab
2003; 88: 2037-2044.
29. Gauna C, Meyler FM, Janssen JAMJL, Delhanty PJD, Abribat
T, van Koetsveld P, Hofland LJ, Broglio F, Ghigo E, van
der Lely AJ. Administration of Acylated Ghrelin Reduces Insulin
Sensitivity, Whereas the Combination of Acylated Plus
Unacylated Ghrelin Strongly Improves Insulin Sensitivity. J
Clin Endocrinol Metab 2004; 89: 5035-5042.
30. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P,
Fairclough P, Bhattacharya S, Carpenter R, Grossman AB,
Korbonits M. The tissue distribution of the mRNA of ghrelin
and subtypes of its receptor, GHS-R, in humans. J Clin
Endocrinol Metab 2002; 87: 2988-2991.
31. Grube D, Forssmann WG. Morphology and function of the
entero-endocrine cells. Horm Metab Res 1979; 11: 589-606.
32. Gualillo O, Caminos JE, Kojima M, Kangawa K, Arvat E,
Ghigo E, Casanueva FF, Dieguez C. Gender and gonadal influences
on ghrelin mRNA levels in rat stomach. Eur J Endocrinol
2001; 144: 687-690.
33. Halem HA, Taylor JE, Dong JZ, Shen Y, Datta R, Abizaid A,
Diano S, Horvath T, Zizzari P, Bluet-Pajot MT, Epelbaum J,
Culler MD. Novel analogs of ghrelin: physiological and clinical
implications. Eur J Endocrinol 2004; 151: 71-75.
34. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H,
Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K,
Nakao K. A low dose of ghrelin stimulates growth hormone
(GH) release synergistically with GH-releasing hormone in
humans. J Clin Endocrinol Metab 2001; 86:552-4555.
35. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and
des-acyl ghrelin: two major forms of rat ghrelin peptide in
gastrointestinal tissue. Biochem Biophys Res Commun
2000; 279: 909-913.
36. Hosoda H, Kojima M, Matsuo H, Kangawa K. Purification
and characterization of rat des-Gln14-Ghrelin, a second endogenous
ligand for the growth hormone secretagogue receptor.
J Biol Chem 2000; 275: 21995-22000.
37. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa
K. Structural divergence of human ghrelin. Identification of
multiple ghrelin-derived molecules produced by posttranslational
processing. J Biol Chem 2003; 278: 64-70.
38. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E,
Enomoto M, Ono F, Kangawa K. Optimum collection and
storage conditions for ghrelin measurements: octanoyl modification
of ghrelin is rapidly hydrolyzed to desacyl ghrelin in
blood samples. Clin Chem 2004; 50: 1077-1080.
39. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka
H, Kondo C, Kojima M, Kangawa K, Sugihara S. Fasting
plasma ghrelin levels are negatively correlated with insulin
resistance and PAI-1, but not with leptin, in obese children
and adolescents. Diabetes 2002; 51: 3408-3411.
40. Janssen JA, Der Toorn FM, Hofland LJ, van Koetsveld P,
Broglio F, Ghigo E, Lamberts SW, Jan VDL. Systemic ghrelin
levels in subjects with growth hormone deficiency are not
modified by one year of growth hormone replacement therapy.
Eur J Endocrinol 2001; 145: 711-716.
41. Kangawa K, Matsuo H. Purification and complete amino
acid sequence of alpha-human atrial natriuretic polypeptide
(alpha-hANP). Biochem Biophys Res Commun 1984; 118:
131-139.
42. Kato M, Sakuma Y. The effect of GHRP-6 on the intracellular
Na+ concentration of rat pituitary cells in primary culture.
J Neuroendocrinol 1999; 11: 795-800.
43. Katugampola SD, Kuc RE, Maguire JJ, Davenport AP. Gprotein-
coupled receptors in human atherosclerosis: comparison
of vasoconstrictors (endothelin and thromboxane) with
recently de- orphanized (urotensin-II, apelin and ghrelin) receptors.
Clin Sci 2002; 103: 171-175.
Grelin ve fonksiyonu
‹stanbul T›p Fakültesi Dergisi Cilt / Volume: 70 • Say› / Number: 3 • Y›l/Year: 2007
- 90 -
44. Kim MS, Yoon CY, Park KH, Shin CS, Park KS, Kim SY,
Cho BY, Lee HK. Changes in ghrelin and ghrelin receptor
expression according to feeding status. NeuroReport 2003;
14: 1317-1320.
45. Kitamura S, Yokota I, Hosoda H, Kotani Y, Matsuda J, Naito
E, Ito M, Kangawa K, Kuroda Y. Ghrelin concentration
in cord and neonatal blood: Relation to fetal growth and
energy balance. J Clin Endocrinol Metab 2003; 88: 5473-
5477.
46. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa
K. Ghrelin is a growth-hormone-releasing acylated
peptide from stomach. Nature 1999; 402: 656-660.
47. Korbonits M, Ciccarelli E, Ghigo E, Grossman AB. The
growth hormone secretagogue receptor. Growth Horm 1999;
9: 93-99.
48. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF,
Lowe DG, Kangawa K, Grossman AB. The expression of the
growth hormone secretagogue receptor ligand ghrelin in normal
and abnormal human pituitary and other neuroendocrine
tumors. J Clin Endocrinol Metab 2001; 86: 881-887.
49. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB.
Ghrelin—a hormone with multiple functions. Frontiers in
Neuroendocrinology 2004; 25: 27-68.
50. Makino Y, Hosoda H, Shibata K, Makino I, Kojima M, Kangawa
K, Kawarabayashi T. Alteration of plasma ghrelin levels
associated with the blood pressure in pregnancy. Hypertension
2002; 39: 781-784.
51. Marchesini G, Pagotto U, Bugianesi E, De Iasio R, Manini
R, Vanni E, Pasquali R, Melchionda N, Rizzetto M. Low
ghrelin concentrations in nonalcoholic fatty liver disease are
related to insulin resistance. J Clin Endocrinol Metab 2003;
88:5674-5679.
52. Masaoka T, Suzuki H, Hosoda H, Ota T, Minegishi Y, Nagata
H, Kangawa K, Ishii H. Enhanced plasma ghrelin levels in
rats with streptozotocin-induced diabetes. FEBS Lett 2003;
541: 64-68.
53. McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk
DL, Smith RG, Howard AD, Van der Ploeg LH. Cloning
and characterization of two human G protein-coupled receptor
genes (GPR38 and GPR39) related to the growth hormone
secretagogue and neurotensin receptors. Genomics 1997;
46:426-434.
54. Miraglia del Giudice E, Santoro N, Cirillo G, Raimondo P,
Grandone A, D'Aniello A, Di Nardo M, Perrone L. Molecular
screening of the ghrelin gene in Italian obese children: the
Leu72Met variant is associated with an earlier onset of obesity.
Int J Obes Relat Metab Disord 2004; 28: 447-450.
55. Morton GJ, Schwartz MW. The NPY/AgRP neuron and
energy homeostasis. Int J Obesity Relat Metab Disord 2001;
25: 56-62.
56. Muccioli G, Pons N, Ghe C, Catapano F, Granata R, Ghigo
E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced
lipolysis in rat adipocytes via a non-type 1a growth
hormone secretagogue receptor. Eur J Pharmacol 2004; 498:
27-35.
57. Muller AF, Janssen JA, Hofland LJ, Lamberts SW, Bidlingmaier
M, Strasburger CJ, Der Lely AJA. Blockade of the
growth hormone (GH) receptor unmasks rapid GH-releasing
peptide-6-mediated tissue-specific insulin resistance. J Clin
Endocrinol Metab 2001; 86: 590-593.
58. Murdolo G, Lucidi P, Di Loreto C, Parlanti N, De Cicco A,
Fanelli C, Perriello G, Mughetti D, Pippi R, Brozzetti A,
Santeusanio F, De Feo P. Circulating ghrelin levels of visceral
obese men are not modified by a short-term treatment
with very low doses of GH replacement. J Endocrinol Invest
2003; 26: 244-249.
59. Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M,
Okumura H, Hosoda H, Shimizu W, Yamagishi M, Oya H,
Koh H, Yutani C, Kangawa K. Elevated circulating level of
ghrelin in cachexia associated with chronic heart failure: relationships
between ghrelin and anabolic/catabolic factors.
Circulation 2001; 104: 2034-2038.
60. Ott V, Fasshauer M, Dalski A, Meier B, Perwitz N, Klein
HH, Tschop M, Klein J. Direct peripheral effects of ghrelin
include suppression of adiponectin expression. Horm Metab
Res 2002; 34: 640-645.
61. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl
RL, Heiman ML, Lehnert P, Fichter M, Tschöp M. Weight
gain decreases elevated plasma ghrelin concentrations
of patients with anorexia nervosa. Eur J Endocrinol 2001;
145: 669-673.
62. Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschöp
M, Pasquali R. Plasma ghrelin, obesity, and the polycystic
ovary syndrome: correlation with insulin resistance and androgen
levels. J Clin Endocrinol Metab 2002; 87: 5625-5629.
63. Papotti M, Ghe C, Volante M, Muccioli G. Ghrelin and tumors.
In: Ghrelin (More Than Simply a Natural GH Secretagogue
and/or on Orexigenic Factor) (ed. E. Ghigo), Kluwer
Academic, Boston, 2004; 143-164.
64. Pemberton C, Wimalasena P, Yandle T, Soule S, Richards M.
C-terminal pro-ghrelin peptides are present in the human circulation.
Biochem Biophys Res Commun 2003; 310: 567-
573.
65. Pettersson I, Muccioli G, Granata R, Deghenghi R, Ghigo E,
Ohlsson C, Isgaard J. Natural (ghrelin) and synthetic (hexarelin)
GH secretagogues stimulate H9c2 cardiomyocyte cell
proliferation. J Endocrinol 2002; 175: 201-209.
66. Pong SS, Chaung LY, Dean DC, Nargund RP, Patchett AA,
Smith RG. Identification of a new G-protein-linked receptor
for growth hormone secretagogues. Mol Endocrinol 1996;
10: 57-61.
67. Poykko S, Ukkola O, Kauma H, Savolainen MJ, Kesaniemi
YA. Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes
and hypertension in a random sample of middle-aged
subjects. Diabetologia 2003; 46: 455-458.
68. Pöykkö SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi
YA, Ukkola O. Low plasma ghrelin is associated with insulin
resistance, hypertension, and the prevalence of type 2 diabetes.
Diabetes 2003; 52: 2546-2553.
69. Purnell JQ, Weigle DS, Breen PA,Cummings DE. Ghrelin
levels correlate with insulin levels, insulin resistance, and
high-density lipoprotein cholesterol, but not with gender,
menopausal status, or cortisol levels in humans. J Clin Endocrinol
Metab 2003; 88: 5747-5752.
Ghrelin and functions
‹stanbul T›p Fakültesi Dergisi Cilt / Volume: 70 • Say› / Number: 3 • Y›l/Year: 2007
- 91 -
70. Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JO.
Hyperthyroidism is associated with suppressed circulating
ghrelin levels. J Clin Endocrinol Metab 2003; 88: 853-857.
71. Ruter J, Kobelt P, Tebbe JJ, Avsar Y, Veh R, Wang L, Klapp
BF, Wiedenmann B, Tache Y, Monnikes H. Intraperitoneal
injection of ghrelin induces Fos expression in the paraventricular
nucleus of the hypothalamus in rats. Brain Res 2003;
991: 26-33.
72. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka
M, Nozoe S, Hosoda H, Kangawa K, Matsukura S.
Plasma ghrelin levels in lean and obese humans and the effect
of glucose on ghrelin secretion. J Clin Endocrinol Metab
2002; 87: 240-244.
73. Smith RG, LHT, Van der Ploeg AD. H, Feighner SD, Cheng
K, Hickey GJ, Wyvratt MJ, Fisher Jr, MH., Nargund RP,
Patchett AA. Peptidomimetic regulation of growth hormone
secretion. Endocr Rev 1997; 18: 621-645.
74. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto
A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa
Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao
K. Ghrelin strongly stimulates growth hormone release in
humans. J Clin Endocrinol Metab 2000; 85: 4908-4911.
75. Thompson NM, Gill DA, Davies R, Loveridge N, Houston
PA, Robinson IC, Wells T. Ghrelin and des-octanoyl ghrelin
promote adipogenesis directly in vivo by a mechanism independent
of the type 1a growth hormone secretagogue receptor.
Endocrinology 2004; 145:234-242.
76. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity
in rodents. Nature 2000; 407: 908-913.
77. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin
E, Heiman ML, Circulating ghrelin levels are decreased
in human obesity. Diabetes 2001; 50: 707–709.
78. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological,
physiological, pathophysiological, and pharmacological
aspects of ghrelin. Endocr Rev 2004; 25: 426-457.
79. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi
R, Muccioli G, Ghigo E, Papotti M. Expression of
ghrelin and of the GH secretagogue receptor by pancreatic
islet cells and related endocrine tumors. J Clin Endocrinol
Metab 2002; 87:1300-1308.
80. Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held
K, Mathias S, Schmid DA, Uhr M, Steiger A. Ghrelin promotes
slow-wave sleep in man. Am J Physiol Endocrinol
Metab 2002; 284: 407-415.
81. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin
cell: A novel developmentally regulated islet cell in the human
pancreas. Regul Pept 2002; 107:63-69.
82. Wisse BE, Frayo RS, Schwartz MW, Cummings DE. Reversal
of cancer anorexia by blockade of central melanocortin
receptors in rats. Endocrinology 2001; 142: 3292-3301.
Thank you for copying data from http://www.arastirmax.com
